Gas chromatographic determination of 2- and 3-dechloroethylifosfamide in plasma and urine

J Chromatogr. 1992 Dec 2;583(2):175-82. doi: 10.1016/0378-4347(92)80550-a.

Abstract

The metabolic oxidation of one of the chloroethyl groups of the antitumour drug ifosfamide leads to the formation of the inactive metabolites 2- and 3-dechloroethylifosfamide together with the neurotoxic metabolite chloroacetaldehyde. A very sensitive capillary gas chromatographic method, requiring only 50 microliters of plasma or urine, has been developed to measure the amounts of the drug and the two inactive metabolites in a single run. Calibration curves were linear (r > 0.999) in the concentration ranges from 50 ng/ml to 100 micrograms/ml in plasma and from 100 ng/ml to 1 mg/ml in urine.

MeSH terms

  • Chromatography, Gas / instrumentation
  • Chromatography, Gas / methods*
  • Colonic Neoplasms / blood
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / urine
  • Cyclophosphamide / analogs & derivatives*
  • Cyclophosphamide / analysis
  • Cyclophosphamide / blood
  • Cyclophosphamide / urine
  • Humans
  • Ifosfamide / analogs & derivatives*
  • Ifosfamide / analysis
  • Ifosfamide / blood
  • Ifosfamide / metabolism
  • Ifosfamide / therapeutic use
  • Ifosfamide / urine
  • Male
  • Middle Aged
  • Reproducibility of Results

Substances

  • dechloroethylcyclophosphamide
  • Cyclophosphamide
  • dechloroethylifosfamide
  • Ifosfamide